Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Apr;63(4):522–526. doi: 10.1038/bjc.1991.124

Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model.

H Yanagië 1, T Tomita 1, H Kobayashi 1, Y Fujii 1, T Takahashi 1, K Hasumi 1, H Nariuchi 1, M Sekiguchi 1
PMCID: PMC1972354  PMID: 2021537

Abstract

An immunoliposome containing a 10B-compound has been examined as a selective drug delivery system in boron neutron-capture therapy. Liposomes, conjugated with monoclonal antibodies specific for carcinoembryonic antigen (CEA) were shown to bind selectively to cells bearing CEA on their surface. The immunoliposomes attached to tumour cells suppressed growth in vitro upon thermal neutron irradiation and suppression was dependent upon the concentration of the 10B-compound in the liposomes and on the density of antibody conjugated to the liposomes. The results suggest that immunoliposomes containing the 10B-compound could act as a selective and efficient carrier of 10B atoms to target tumour cells in boron neutron-capture therapy.

Full text

PDF
522

Images in this article

523Figure 1
on p.523

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam F., Soloway A. H., McGuire J. E., Barth R. F., Carey W. E., Adams D. Dicesium N-succinimidyl 3-(undecahydro-closo-dodecaboranyldithio)propionate, a novel heterobifunctional boronating agent. J Med Chem. 1985 Apr;28(4):522–525. doi: 10.1021/jm00382a026. [DOI] [PubMed] [Google Scholar]
  2. Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965 Aug;13(1):238–252. doi: 10.1016/s0022-2836(65)80093-6. [DOI] [PubMed] [Google Scholar]
  3. Barbet J., Machy P., Leserman L. D. Monoclonal antibody covalently coupled to liposomes: specific targeting to cells. J Supramol Struct Cell Biochem. 1981;16(3):243–258. doi: 10.1002/jsscb.1981.380160305. [DOI] [PubMed] [Google Scholar]
  4. Barth R. F., Soloway A. H., Fairchild R. G. Boron neutron capture therapy of cancer. Cancer Res. 1990 Feb 15;50(4):1061–1070. [PubMed] [Google Scholar]
  5. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goldenberg D. M., Sharkey R. M., Primus F. J., Mizusawa E., Hawthorne M. F. Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system. Proc Natl Acad Sci U S A. 1984 Jan;81(2):560–563. doi: 10.1073/pnas.81.2.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hashimoto Y., Sugawara M., Masuko T., Hojo H. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Cancer Res. 1983 Nov;43(11):5328–5334. [PubMed] [Google Scholar]
  8. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  9. Ikeuchi I., Amano T. A colorimetric determination of boron in biological materials. Chem Pharm Bull (Tokyo) 1978 Sep;26(9):2619–2623. doi: 10.1248/cpb.26.2619. [DOI] [PubMed] [Google Scholar]
  10. Konno H., Suzuki H., Tadakuma T., Kumai K., Yasuda T., Kubota T., Ohta S., Nagaike K., Hosokawa S., Ishibiki K. Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody. Cancer Res. 1987 Aug 15;47(16):4471–4477. [PubMed] [Google Scholar]
  11. Kruger P. G. Some Biological Effects of Nuclear Disintegration Products on Neoplastic Tissue. Proc Natl Acad Sci U S A. 1940 Mar 15;26(3):181–192. doi: 10.1073/pnas.26.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Leserman L. D., Machy P., Barbet J. Cell-specific drug transfer from liposomes bearing monoclonal antibodies. Nature. 1981 Sep 17;293(5829):226–228. doi: 10.1038/293226a0. [DOI] [PubMed] [Google Scholar]
  14. Martin F. J., Hubbell W. L., Papahadjopoulos D. Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds. Biochemistry. 1981 Jul 7;20(14):4229–4238. doi: 10.1021/bi00517a043. [DOI] [PubMed] [Google Scholar]
  15. Mishima Y., Honda C., Ichihashi M., Obara H., Hiratsuka J., Fukuda H., Karashima H., Kobayashi T., Kanda K., Yoshino K. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet. 1989 Aug 12;2(8659):388–389. doi: 10.1016/s0140-6736(89)90567-9. [DOI] [PubMed] [Google Scholar]
  16. Mizusawa E., Dahlman H. L., Bennett S. J., Goldenberg D. M., Hawthorne M. F. Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1982 May;79(9):3011–3014. doi: 10.1073/pnas.79.9.3011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SWEET W. H. The uses of nuclear disintegration in the diagnosis and treatment of brain tumor. N Engl J Med. 1951 Dec 6;245(23):875–878. doi: 10.1056/NEJM195112062452301. [DOI] [PubMed] [Google Scholar]
  18. Sullivan S. M., Huang L. Preparation and characterization of heat-sensitive immunoliposomes. Biochim Biophys Acta. 1985 Jan 10;812(1):116–126. doi: 10.1016/0005-2736(85)90528-0. [DOI] [PubMed] [Google Scholar]
  19. Takahashi T., Fujii Y., Fujii G., Nariuchi H. Preliminary study for application of anti-alpha-fetoprotein monoclonal antibody to boron-neutron capture therapy. Jpn J Exp Med. 1987 Apr;57(2):83–91. [PubMed] [Google Scholar]
  20. Tanaka T., Suzuki S., Masuko T., Hashimoto Y. In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen. Jpn J Cancer Res. 1989 Apr;80(4):380–386. doi: 10.1111/j.1349-7006.1989.tb02323.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tsukada Y., Bischof W. K., Hibi N., Hirai H., Hurwitz E., Sela M. Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells. Proc Natl Acad Sci U S A. 1982 Jan;79(2):621–625. doi: 10.1073/pnas.79.2.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yeagle P. L. Cholesterol and the cell membrane. Biochim Biophys Acta. 1985 Dec 9;822(3-4):267–287. doi: 10.1016/0304-4157(85)90011-5. [DOI] [PubMed] [Google Scholar]
  23. von Kleist S., Chavanel G., Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2492–2494. doi: 10.1073/pnas.69.9.2492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES